Human dermal fibroblasts grown in tissue culture can be suspended and cultured in collagen lattices. These fibroblast-populated collagen lattices (FPCL) undergo a reduction in size by the process of lattice contraction. Fibroblasts from patients with epidermolysis bullosa dystrophica recessive, EBdr, produce excessive quantities of cAMP. These high concentrations of cAMP may be related to the inability of the EBdr fibroblast to elongate and spread out when incorporated into the collagen matrix. Fibroblasts with these morphologic characteristics are not effective in contracting collagen lattices. EBdr fibroblasts in FPCL have intracellular concentrations of cAMP 8 times greater than those of normal fibroblasts in FPCL. They also have a dendritic morphology. The addition of cholera toxin or dibutyryl cAMP to normal human fibroblasts will cause elevated levels of intracellular cAMP and will inhibit the elongation and spreading of cells and lattice contraction. The cytoskeletal morphology of EBdr fibroblasts differs from that of normal human fibroblasts in FPCL. The use of rhodamine phalloidin, a specific fluorescent stain for F-actin filaments, reveals that EBdr fibroblasts show a pattern of actin distribution shared by normal fibroblasts cultured in the presence of dibutyryl cAMP or cholera toxin. It is proposed that the contractile forces responsible for lattice contraction are identical to those forces responsible for the spreading and elongation of cells. EBdr fibroblasts fail to spread and elongate within a collagen matrix and are therefore not effective in lattice contraction.
Human dermal fibroblasts grown in tissue culture can be suspended and cultured in collagen lattices. These fibroblast-populated collagen lattices (FPCL) undergo a reduction in size by the process of lattice contraction. Fibroblasts from patients with epidermolysis bullosa dystrophica recessive, EBdr, produce excessive quantities of cAMP. These high concentrations of cAMP may be related to the inability of the EBdr fibroblast to elongate and spread out when incorporated into the collagen matrix. Fibroblasts with these morphologic characteristics are not effective in contracting collagen lattices. EBdr fibroblasts in FPCL have intracellular concentrations of cAMP 8 times greater than those of normal fibroblasts in FPCL. They also have a dendritic morphology. The addition of cholera toxin or dibutyryl cAMP to normal human fibroblasts will cause elevated levels of intracellular cAMP and will inhibit the elongation and spreading of cells and lattice contraction. The cytoskeletal morphology of EBdr fibroblasts differs from that of normal human fibroblasts in FPCL. The use of rhodamine phalloidin, a specific fluorescent stain for F-actin filaments, reveals that EBdr fibroblasts show a pattern of actin distribution shared by normal fibroblasts cultured in the presence of dibutyryl cAMP or cholera toxin. It is proposed that the contractile forces responsible for lattice contraction are identical to those forces responsible for the spreading and elongation of cells. EBdr fibroblasts fail to spread and elongate within a collagen matrix and are therefore not effective in lattice contraction.
Epidermolysis bullosa dystrophica recessive, EBdr, is an inherited disease clinica ll y characterized by induction of bliste rs in skin and mucosal surfaces by minor trauma [1] . The an ato mic location of the blister formation in skin is between the basement membrane plane a nd t he papillary dermal layer. The structure of collagen fibers within the papillary dermis of t he affected area shows breakdown and locali zed destruction [2] . Tissue-cult ured fibrobla sts derived from patients with EBdr show an increased synthesis and secretion of mammalian collage nase [3, 4 ] . The EBdr collagenase appears to be structurManusc ript received March 13, 1984 ; accepted for publication April 25, 1984 ally altered, havin g a lower thermal stability and a lower affinity for its metal cofactor calcium [5] [6] [7] . EBdr fibroblasts entrapped in a collagen matrix have a dendritic appearance as demonstrated with phase contrast optics and scanning electron microscopy [8) . In contrast, normal human fibroblasts within a collagen matrix have an elongated and bipolar spread-out appearance [8, 9] . Fibroblasts incorporated into a collagen matrix reduce the size of that matrix by the process referred to as lattice contraction [9] . EBdr fibroblasts incorporated into a collagen lattice show an inability to spread out and they are less effective in contracting a collagen lattice.
Fibroblast-like cells isolated from the synovium of rheumatic arthritic joints have a dendritic morphology [10] . These dendritic cells produce increased amounts of collagenase and prostaglandin E 2 (PGE2) [11 ,12] . Elevated levels of PGE 2 will promote enhanced synthesis of int racellular cAMP [13 ] . Since EBdr fibroblasts reportedly produce excess amounts o f collagenase and PGE~. the possibility exists that these cells a lso produce increased amou nts of intracellular cAMP. Increased intracellular concentrations of PGs a lter cell morphology within the collagen lattice and inhibit lattice contraction [14, 15) . In this study the EBdr fibroblasts within fibroblastpopulated collagen lattices (FPCL) were assayed for cAMP. The effect of indomethacin, a nonsteroid anti-inflammatory drug, on the inhibition of the synthesis of PGs and intracellular cAMP was measured. In EBdr cells, the reduction by indomethacin of intracellular cAMP levels produced a normal morphologic appearance within the FPCL and promoted normal lattice contraction.
MATERIALS AND METHODS
The pepsin-solubilized collagen used in these studies was extracted from a benign uterine neoplasm, leiomyoma. After su rgical removal and pathologic examination, leiomyomas were frozen and powdered in a Spex Freezing Mill, (Metuchen, New Jersey). This fresh powdered tissue was taken up in 0.5 M acetic acid with 0.1% pepsin w/ v, stirred at 2· c for 48 h, then centrifuged at 10,000 g for 10 min, and the collagen-rich supernatant was saved. The supernatant was neutralized with 2 M sodium hydroxide, and sodium chloride was added to a final concentration of 20% w/v. The mixture was stirred overnight at 2·c, then centrifuged at 10,000 g for 15 min and the pellet saved. The pellet was suspended in 0.1 M acetic acid and dialyzed against 1 mM hydrochloric ac id. The collagen solution was cleared by centrifugation at 10,000 g for 30 min, and the supernatant was frozen, lyophilized, weighed, and taken up in sterile 1 mM hydrochloric acid at a concentration of 5 mg/ml. The collagen solution was kept at 2· c unt il needed.
Dulbecco's modification of Eagle's medium (DMEM) containing a final concentrate of 20% v/v fetal bovine serum (FBS) and 25 J.Lg/ml gentamicin was used in all the noted experiments. Fibroblasts for these experiments were described previously [8, 15] ; the EBdr cell lines used were gifts from Dr. H. P. Baden, Dermatology Service, Massachusetts Gene ral Hospital. Dr. A. Mulinski, Boston University Medical Center, supplied cell line 3358 which is the parent of EBdr fibroblast line 3592. Dr. R. W. Erbe, Pediatrics Department, Massachusetts General Hospital, supplied the normal fibroblast line MGH 287 which is agematched to t he EBdr cell line studied.
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FPCL were manufactured by rapidly mixing together in a 35-mm bacteriologic Petri dish 1 ml of culture medium, 0.5 ml of the fibroblasts suspended in the same medium, and 0.5 ml of cold collagen solution in 1 mM hydroch loric acid. The collagen polymerized in less t han 2 min
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EFFECT OF CAMP ON FIBROBLAST COLLAG EN LATTICE CONTRACTION 231 at 3 7 • c in 5% C0 2 and 95% moist air atmosphere, entrapping fibro· b lasts wi thin its polymeri zed matri x.
A ge nts we re added to the medium prior to the mi xing of cells, mediu m, and collagen. Indomethacin, (Sigma, St. Louis, Missouri) , was adde d at the co nce ntration of 10 pg/ ml. Cycl ic nucleotide preparatio ns, cAMP and dibu tyryl (db) cA MP (Sigma) were used at 10-3 and 10-6 M fi n a l concentrations. Cholera tox in (S igma) was used at 1 x 10-6 and 5 x 1 0 -6 M. T he area of t he FPCL was reco rded directly by measuring t he dia meter to the nea rest 0.5 mm .
A p ort ion of t he lattice was cut and t ransferred to a glass coverslip for morphologic examination. The specimens were t hen covered wit h glass microscope slides and exa mined. Fibroblast morphology was doc u mented with a Zeiss IM 35 inve rted microscope equipped wi th Nomar ski optics and epifluoresce nce. Panatomic X 35-mm film was used to photograph cells wi thin lattices. For flu orescent studies Kodak Ektac hrome 400 ASA 35-mm film was used and uprated to 1600 ASA du ring processing.
Sta ining for F-actin fil amentous stress fib ers was accomplished with rh od a mine phalloidin (Rb-phalloidin) (Molec ul ar Probes, Inc., Oregon) (16] . P halloidin is a mushroom toxin whi ch binds specifically to Factin [1 7] . FPCL on glass coverslips we re fi xed for 5 min in 4% paraformaldehyde, was hed 3 times in phys iologic buffered saline (PBS) a nd t h e n permea bilized with 0. 1% Triton X-100 in PBS for 5 min. The specimen was was hed aga in 3 times with PBS and incubated for 30 m in in Rb -phalloidin at 1:100 dilut ion in PBS. Coverslips were was hed 3 t imes in PBS, moun ted in 9: 1 glycerol:PBS and examined wit h epi flu orescence using the appropriate rh odamine fil te rs.
Con cent rations of cAMP we re measured in 48-h-old lattices. The medi um was removed at 48 h and the populated lattice was extracted in 5 % t richl oroacetic ac id (TCA) using the instructions furnished wit h the c AM P radioimmunoassay kits purchased from Boehringer Mann · heim (Indianapolis, Indiana). The calculated co ncent rations of cAMP from t h e radi oimmunoassay results utilized a published log-logit procedure applica ble to a hand -held calculator [1 8] . Data was statistically aver aged using a nonpaired Student's t-test.
RESULTS

Lattice Contraction and cAMP Concentration
A fte r 48 h in cul t ure, FPCL ini t ia lly con taining 70,000 cells wer e assayed for cAMP. N orma l M GH -287 fibroblast lattices h a d 0 . 46 (Table I, experiment 1) . Th e direct addit ion of cAMP to norma l FPCL at 10-4 M t o 10-3 M did not a lter lattice con t raction at 48 h (Fig 1) . This was to be expected since fibroblasts cannot take up cAMP. Unlike cAMP, db cAMP is taken up by fibroblast s and incr e a ses intrace llula r level s of cAMP. Lat tice con t rac tion was inhi bited at 48 h by t he addi t ion of db cAMP at w-r, M to w-: 1 M (Fig 1) . The inhibitory activity of db cAMP is dose-dependent fr o m 10-6 M to w-a M . A con t rol experiment wi t h t he addi t ion of butanol to FPCL at 0.1% v /v did not alter lattice contraction at 48 h.
C h o ler a to xin stimulates adenylate cyclase activity and increases cAMP synt hesis and acc umulat ion . Treated norma l MGH -287 fibroblasts in FPCL ha d cAMP levels of 6.06 pmol per 10,000 cells compa red to 0.46 pmol per 10,000 cells in u n t reated con t rols a t 48 h (Tabl e I, experiment 2) . The addition of c h o lera t oxin to m edium durin g the manufacture of normal F P C L inhibited lattice contract ion (Table I, experiment 2) . Hen ce, t h e stimulation of adenylate cyclase by cholera toxin p r omot ed t he synthesis and int racellular accumulation of cAMP , result ing in retarded FPCL con t raction. PGE 2 can stimulate adenylate cyclase activity, thereby causing t h e int racellular accumulation of cAMP. When norma l human fibroblasts we re incorporated into FPCL in t he presence of P GE 2 , lattice cont ract ion was inhibited a nd cAMP levels we r e 6.80 pmol pe r 10,000 compa red to 0.46 pmol per 10,000 in untr eated con t rols (T able I, experiment 3 ). EBdr fibroblasts produce elevated levels of PGE 2 [1 5 ]. EBdr FPCL made in t he presen c e of indomethacin , a cyclooxygen ase inhibitor, sh owed FPCL we re made with 7 x 10' fi broblasts pe r 2 ml of lattice. T he lattices were measured at 48 h and cA MP levels were assayed at t hat ti me. 
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Dose-dependent response of added cyclic nucleotides on lattice contraction. FPCL were manu factured with 70,000 normal human fibroblasts, 20% v/ v FBS, 2.5 mg soluble collagen, and DMEM with addit ions to a fin al volume of 2.0 ml in 35-mm Petri dishes. Lattice area was reco rded at 48 h: The addi tion of cAM P (identified by open boxes) d1d not affect latt1ce contractiOn. The addit ion of db cAMP (iden t ified by solid triangles ), which is taken up by cells, inhibited latt1ce contraction m a dose-dependent response. levels of cAMP reduced to 0.76 pmol p er 10,000 cells (T able I, experiment 3) and lattice con t raction iden tical to t hat in t he norma l FPC L.
Fibroblast M orphology
EBdr fibroblasts en t rapped in a collagen lattice do not spread out or elongate as well as norma l fibroblasts [8 ] . Di ffe rences between t he a ffect ed a nd norma l fibroblasts were readily demonstrated at 24 h by N oma rski opt ics (Fig 2A, B) . The addi t ion of db cAMP at 2 X 10-3 M t o normal MGH-287 FPCL a lte red fibroblast morphology at 24 h (Fig 2C ) and inhibit ed lattice co nt raction . The db cAMP inhibited t he ability of fibroblasts to spread out and elongat e. S imila rly, t he addition of cholera to xin to norma l fibroblasts alte red t heir morphology (Fig 2D ) and inhibited cont raction . PGE 2 , like cholera toxin , prom oted t he syn t hesis of int racellular cAMP (T able I) . The additio n of indomethacin to EBdr FPCL inhibited t he synt hesis of PGE 2 and cAMP, a nd promoted t he spreading of cells (Fig 2E) . It is clear t hat t he elevation of int racellular cAMP levels by db cAMP, cholera toxin , or PGE 2 affects t he morphology of norma l huma n fibroblasts in FPCL. Treated n orma l huma n fibroblasts look like E Bdr fibroblasts. Pie-s haped wedges were cut from 48-h-old FPCL made with norma l or EBdr hum an fibroblasts and we re transferred to glass coverslips. Tissue on the cove rsli ps was fixed, permeabilized, and incubated with Rbphalloidin , and then mounted and exam ined wi th epif1uoresce nce. Bars = 10 /.lm . A , FPCL made wi th 50,000 norm al hum an fibrobl asts show elongated fibroblasts with actin fil ame nts in the long arm s of the cells. T hese cells are located at t he periphery of the lattice. B, FPCL made with 70,000 fibroblasts, 3592 cells, show fibrobl asts with dendritic arm s hav ing stained actin fil aments in t hese numerous fil opodia. These cells are located at the periphery of t he lattice. C, FPCL with 50,000 normal hum an librobla ·ts and 10-4 M db cAMP show actin fi lame nts wit hin t.he num erous dendritic arms of this cell. D, FPCL made with 10-6 M cholera tox in and norm al human fibroblasts show a dendritic cell shape with stained filaments within the dendri t ic arm s. E, FPCL made with 5 l.lg/ml of PGE~ and normal hum an fibroblasts show numerous fil aments within the dendri tic arm s of the cells. F, FPCL made with indomethac in , 10 l.lg/ml, and EBdr fibroblasts show a spindle-shaped cell with diffuse microfil aments within the bipolar arms of the cell.
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by the transfe r of pie-shaped wedges from t he lattices to glass coverslips. FPCL were made wit h 50 ,000-70,000 fibroblasts, FBS, soluble collagen, and DMEM . Agents we re included in t he ini tial manufacture of lattices. Bars = 10 /.lm . A, Normal human fibroblasts show this typical elongated shape in FPCL. B, EBdr 3592 fibrobl asts show t his dendritic morphology. They are less effective at elongating and spreading out wit hin the collagen matri x. C, Normal human fibroblasts in t he presence of 10-• M db cAMP have a dendrit ic morphology similar to EBdr cells. D, Normal human fibroblasts in FPCL made with 5 X 10-6 M cholera toxin show dendri tic cellular morphology. E, T he addition of indomethac in at 10 /.lg/ml to EBdr FPCL reduced cA MP concent ration and produced a cell morphology like t hat of normal human fibrobl asts.
F ibroblast cytoskeleta l structures within FPCL we re examined by Rb-phalloidin staining of lattices 24 h after manufacture. Normal human FPCL show ve ry fine F-actin microfilamen ts in the cytoplasm (Fig 3A ) . In cont rast, EBdr FPC L show actin fil ame nts in t he dendritic arms (Fig 3B ) . Their morphologic appeara nce is unlike that of norma l huma n fibroblasts. Adding db cAMP to norma l FPCL p roduces an F -actin filamen t pattern like that of EBdr FPCL (Fig 3C) . S imila rly, treating norma l fibr oblasts with cholera toxin or PGE2 elevates t he intracellular concentrations of cAMP and reveals a n F -actin filament pattern similar to EBdr FPCL (Fig 3D,E) . Making EBdr FPCL in t he presence of indomethacin promoted F-actin fil a ment patte rns simila r to those of normal FPCL (Fig 3 F) .
DISCUSSION
Cultured fibrobl asts deri ved from individua ls affected with EBdr a re morphologically and functiona lly different from normal human fibrob lasts. FPCL made with affected fibroblasts show a lack of fibroblast elongation and spreading which appears responsible for retarded lattice contraction [8) . The alteration of fibroblast morphology and the resulta n t inability to con t ract collage n lattices effectively has been documented in FPCL made with transformed fibroblasts [19] , and in normal FPCL treated with interleukin 1 or PGE, [14, 15] . The addit ion of soluble factor( s) synt hesized by activated monocytes alters t he morphology of fibroblasts, resulting in retarded lattice contraction [1 4 ). It appears t hat the mechanism for sh ape cha nge resulting in retarded lattice contraction is t he promotion of PGE sy nt hesis which stimulates ade nylate cyclase activity and elevates concentrations of intracellular cAMP. EBdr fibroblasts residing in an FPCL synt hesize more PGE 2 t ha n do normal fibroblasts residing within an FPCL [1 5) . There is a 13-fold increase in PGE, co ncen t ration as measured in medium from 48-h EBdr FPCL compared to normal FPCL. The a ddit ion of indomethacin to EBdr FPCL reduces the a mount of PGE synthetized [15) . The addi t ion of indomethacin to normal FPCL neit her a lters t he morphology nor promotes enhanced co ntraction in t hat FPCL. H owever, t he addit ion of indomethacin to EBdr FPCL promotes lattice con traction, cell elongation a nd spreading, and a cytoskeletal morphology identical to t hat of normal human fibroblasts. In addition to inhibiti ng t he synthesis of PGE2, indomethacin a lso reduces t he levels of intracellular cAMP.
PGE~ stimulates adenylate cyclase activity, thereby increas-
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EFFECT OF CAMP ON FIBROBLAST COLLAGEN LATTICE CONTRACTION 233 ing cAMP production [20] . Cholera toxin also stimulates cAMP synthesis within fibroblasts (21 ] . Adding cholera toxin to FPCL made with normal fibroblasts causes re tarded lattice contraction. The direct addition of db cAMP which can be taken up by fibroblasts inhibits FPCL contraction and prevents cell elongation. These treated fibroblasts that are prevented from s preading an d elongating demonstrate retarded lattice contraction. Rhodamine phalloidin-stained monolayer fibroblasts show parallel stress fibers 24 h after plating. Very fine parallel Factin filaments are found at 24 h in normal fibroblasts incorporated into collage n lattices. In contrast, the F -actin filaments in EBdr fibroblasts stain more intensely within the dendritic a rm s of t he cells. This F -actin distribution is simi lar to normal human fibroblasts with elevated levels of cAMP.
Elevated levels of collagenase production reported in monolayer cultured EBdr cells suggest that PGE synthesis may also be elevated [3, 10] . Some cells in primary synovial cell cultures a re spindle shaped. After t he addition of exogenous PGE 2 to these cultured cells, morphologic changes occur resulting in convers ion of their spindle shape to a dendritic form . When PGE is removed from these cells they return to their spindle s hape within 1 h [ 1 3] . Th e direct addition of cholera toxin or db cAMP to the cultured fibroblasts produces a dendritic appearance [22] . Increased intracellular levels of cAMP change the organization of the ce llular microtubules and microfilaments. This consequently alters the cell morphology [23) .
Evidence presented indicates that the increased production of PG E 2 by EBdr fibroblasts leads to elevated intracellular concentrations of cAMP. One effect of these biochemical changes is a retarded spreading and elongation of cells when incorporated i11to a collagen matrix. Microfilaments are essential to the spreading of ce lls. EBdr fibroblast F -actin filaments are present but they are arranged differently than in normal human fibroblasts .
Stopak and Harris proposed that the fibroblast contractile process works by direct physical pulling rather than by a simple contraction of individual cells [24] . Fibroblasts do not shorten in length as co ntracting striated muscle does. They proposed that a "traction force" is responsible for lattice contraction. This is a shearing force, tangential to the cell surface, associated with spreading and elongation of the cell [25] . Fibroblasts may contract a collagen lattice with traction forces identical to those fo rces that promote cell elongation and spreading. The inhibition of these traction forces would result in the absence of the spreading a nd elongation of fibroblasts which would prevent lattice contraction. Traction forces generated by fibroblasts can distort the elastic surfaces beneath the cell [2.5 ). Observations made with FPCL appear to support the Stopak-Harris traction fo rce hypothesis. Lattice contraction occurs by the action of independent cellular forces which appear to be generated by the elongation and spreading of cells. Fibroblasts viewed by phase contrast optics remain elongated throughout the process of lattice contraction.
The inhibition of PGE and cAMP synthesis by the addition of t he nonsteroid anti-inflammatory drug indomethacin to EBdr FPCL may have some clinical value. It is s hown that synovial fibroblasts in tissue culture can be stimulated to produce excess amounts of collagen ase, PGE, and cAMP [10] . Indomethacin blocks PGE synthesis and cAMP accumulation, but it does not alter t he elevated synthesis and secretion of collagenase [12] . Shou ld excess collagenase be the major cause of blistering associated with EBdr syndrome, then the inhibition of PGE synthesis may not be beneficial to the patient. However , if this syndrome is associated with elevated levels of both PGE 2 and intracellular cAMP, then nonsteroid antiinflamma tory drug therapy may be advised.
